Transition Therapeutics (TTHI) Promotes Nicole Rusaw-George to CFO
Transition Therapeutics Inc. (Nasdaq: TTHI) has appointed Nicole Rusaw-George, C.A., as Chief Financial Officer of Transition.
George has been with the Company since 2005 and has served as Vice-President, Finance since 2008. While at Transition, George has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
George has been with the Company since 2005 and has served as Vice-President, Finance since 2008. While at Transition, George has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- AngioDynamics (ANGO) Appoints George Bourne as Tech Chief
- Extreme Networks (EXTR) Taps Cree's (CREE) Kurtzweil as CFO
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
